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A group of 300 clinically derived isolates of coagulase-negative staphylococci were tested in parallel with the API STAPH-IDENT system (Analytab Products) and 14 Coagulase-negative staphylococci (C-NS), formerly regarded as contaminants or only occasionally as opportunistic pathogens, are now the subject of increasing interest. C-NS have frequently been implicated as the etiological agents of various types of human infections, including infections of prostheses (7, 12, 14) , urinary tract infections in young women (3) , and wound infections (8 Conventional identification methods. Micrococci were first differentiated from staphylococci by testing the ability of isolates to produce acid aerobically from glycerol in the presence of erythromycin (11) . Coagulase activity of the staphylococci was determined by using citrated rabbit plasma (Difco Laboratories, Detroit, Mich.) in a 4-h tube test for free coagulase (5) . Strains reacting as C-NS were then classified into species with the following tests contained in Kloos and Schleifer's simplified scheme for routine identification of human Staphylococcus species (4).
(i) Aerobic acid production from carbohydrates. Acid production from nine carbohydrates (lactose, maltose, mannitol, mannose, ribose, sucrose, trehalose, xylitol, and xylose) was observed under aerobic conditions by using purple agar base medium (Difco) containing a 1% final carbohydrate concentration. Acid production was seen as development of a yellow color around the area of growth after 3 days of incubation at 35°C.
(ii) Phosphatase. Alkaline phosphatase activity was determined by a modification of the method of Pennock and Huddy (9) 4 h, the reaction was stopped by adding 0.5 ml of 0.5 N sodium hydroxide and 0.5 ml of 0.5 M sodium bicarbonate. The final color was developed by adding 0.5 ml of 4-aminoantipyrine solution (0.6 g/100 ml) and 0.5 ml of potassium ferricyanide solution (2.4 g/100 ml). Color Table 2 ).
non-CO2 incubator. After incubation, the first nine tests were interpreted, and the results were recorded on API report sheets. Two drops of STAPH-IDENT reagent (0.35% fast blue BB salt in 2-methoxyethanol) were added to the 10th (beta-galactosidase) microcupule, and it was observed for development of a purple color after 30 s. A four-digit profile number was derived for each isolate by tabulating the positive reactions for tests in groups of three. This number was located in API's STAPH-IDENT profile register (provided as a package insert with the STAPH-IDENT strips) to obtain an isolate identification. Strictly for the purpose of this study, API also provided us with a computer printout that represented all possible STAPH-IDENT profiles, a first, second, and third identification choice for each profile number, an "estimated frequency of occurrence" for each choice, and an identification comment. This printout provided information that ordinarily would be available by telephone inquiry to API on a toll-free telephone number.
Resolution of discrepancies. When a discrepancy arose between an isolate's classification by Kloos and Schleifer's simplified scheme (4) and its identification by the API STAPH-IDENT system, the isolate was submitted to Wesley Kloos at North Carolina State University for further testing and final arbitration.
RESULTS
The following seven species of C-NS were encountered in our group of 300 test isolates: Staphylococcus epidermidis (123 isolates), S. saprophyticus (64), S. hominis (48), S. simulans (22), S. haemolyticus (18), S. warneri (17), S. capitis (8) . The accuracy of the STAPH-IDENT system identifications for each species as compared with classification by Kloos and Schleifer's simplified scheme is shown in Table  1 . The use of STAPH-IDENT allowed correct classification of between 71% and 100o of all species tested. This resulted in an overall agreement of 92.7% (278 of 300) when compared with the conventional classification scheme. However, Table 2 shows that, although 63% of the were required for some isolates. There was never more than one supplemental test required for any isolate. These additional tests were suggested in the analytical profile index to separate profiles with similar likelihoods of occurrence. The species incorrectly identified by STAPH-IDENT consisted of 14 S. hominis, 7 S. epidermidis (6 of these were phosphatase negative by both API and conventional methods), and 1 S. saprophyticus isolate. Table 3 shows the STAPH-IDENT analytical profile index (computer printout) comments associated with the C-NS identifications. Sixtyfive percent of the profiles had an associated comment of either "excellent," "very good," "good," or "acceptable." However, 35% (105 of 300) of the identifications were considered to be good likelihood, but low selectivity identifications (GLLS). The presence of a GLLS identification comment indicated that there was no significant difference between the likelihood of species listed as the first, second, or sometimes third choice for a given profile number in the analytical profile index. Two C-NS species were associated with a disproportionate number of GLLS comments; 87% of all S. hominis identifications and 38% of all S. warneri identifications had GLLS profiles. The 22 isolates that were misidentified by STAPH-IDENT included 16 GLLS, 4 acceptable, 1 good, and 1 excellent likelihood profiles. Although all of the 300 C-NS isolates in our study had profile numbers which were listed in API's expanded computer data base (analytical profile index), 14% of the profile numbers were not included in the profile register. The register is a one-page list of profile numbers and corresponding identifications that is included in each STAPH-IDENT kit. Thus, 42 of our isolates would have required telephone contact with API to obtain an identification.
DISCUSSION
We found the STAPH-IDENT system to be extremely convenient to use during the course of this study. Inoculation and interpretation of reactions required a minimum of time and effort. Biochemical reactions, including those involving the chromogenic substrates (alkaline phosphatase, P-glucosidase, ,-glucuronidase, and 3-galactosidase), were generally clear cut and easy to interpret. The 5-h incubation period was seen as an obvious asset over the 3-to 5-day total incubation required for certain of the conventional tests.
The STAPH-IDENT system was able to achieve a high rate of correct identifications, when compared with conventional methods on the two most common human C-NS pathogens, S. epidermidis (94%) and S. saprophyticus (98%), especially when novobiocin was included as a supplemental test. Additionally, two other C-NS species tested (S. haemolyticus and S. simulans) yielded 100% correct identification rates by use of the STAPH-IDENT strip alone. The overall agreement between identifications derived from STAPH-IDENT and conventional methods in our study and that of Kloos and Wolfshohl (6) was greater than 90%.
We initially experienced some difficulties in using Kloos and Schleifer's simplified scheme (4) , particularly in the identification of the few phosphatase-negative S. epidermidis isolates that were often misclassified as S. hominis. However, at Kloos's suggestion, anaerobic growth in thioglycolate was successfully used to differentiate these two species.
Micrococci were very rarely (<1 of 300) isolated from human clinical specimens during the isolate collection phase of our study. However, it should be noted that the STAPH-IDENT data base does not presently include micrococci, and that a Micrococcus species could be erroneously identified as a C-NS species. Thus, for complete accuracy, it might be necessary to perform a preliminary test such as acid from glycerol in the presence of erythromycin to effectively exclude Micrococcus spp.
Our study was in agreement with that of Kloos and Wolfshohl (6) in finding that addition of a novobiocin susceptibility test to the strip or performance of this procedure as a supplemental test could improve the accuracy of C-NS identifications. We have previously reported on a simple means of determining novobiocin susceptibility on Mueller-Hinton agar (1) which may be performed as part of a routine antimicrobial susceptibility test. In addition to a novobiocin susceptibility test, the performance of a rapid coagulase and xylose utilization test in conjunction with STAPH-IDENT would significantly reduce the relatively high percentage (35%) of GLLS identifications (Table 3) .
The majority of profile numbers encountered in this study were listed in the one-page profile register. The profiles included in the profile register are those most commonly encountered and which have the associated comments of either excellent, very good, good, or acceptable identifications. In a few instances, GLLS codes are included in the profile register, and the first and second identification choices are listed. There were 10 of 42 profiles encountered in this study which were not listed on the profile register, but which yielded a correct identification using the STAPH-IDENT strip alone and which had a comment of "acceptable identification" or better in the more complete analytical profile index. Thus, there are certain profiles that should be added to the existing profile register.
Occasionally, the profile register did not correspond exactly to the expanded analytical profile index, e.g., profile no. 2040. The profile register indicated that S. saprophyticus could be differentiated from the second choice, S. hominis, by novobiocin susceptibility testing.
However, the expanded data base listed a GLLS comment and a first identification choice of S. saprophyticus, a second choice of S. epidermidis, and a third choice of S. hominis with corresponding "frequencies of occurrence" of 1 in 13, 1 in 18, and 1 in 24, respectively. Thus, it would seem preferable to make available a more complete profile index for routine use than is provided by the current single-page listing of common profiles.
